Lilly’s Lartruvo Withdrawal Stirs Questions About Payment For Accelerated Approval Drugs

 
• By Sue Sutter
  
Glowing and broken light bulb comparison concept, problem and solution, failure and success, learning from mistake
Lartruvo is coming off the market, thanks to a failed confirmatory study. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip